Acute Phase Proteins in the Acute Phase Response | ISBN 9783540195825

Acute Phase Proteins in the Acute Phase Response

herausgegeben von Mark B. Pepys
Buchcover Acute Phase Proteins in the Acute Phase Response  | EAN 9783540195825 | ISBN 3-540-19582-3 | ISBN 978-3-540-19582-5

Acute Phase Proteins in the Acute Phase Response

herausgegeben von Mark B. Pepys

Inhaltsverzeichnis

  • 1 Interleukin-1 in the Acute Phase Response.
  • The Acute Phase Response.
  • Structure of IL-1.
  • Synthesis and Regulation of IL-1.
  • IL-1 Receptor.
  • Pleotropic Actions of IL-1.
  • IL-1 and Acute Phase Reactions.
  • Fever.
  • Leukocytosis.
  • Acute Phase Proteins.
  • IL-1 and Other Cytokines.
  • Synergy of Action.
  • Induction of Other Cytokines by IL-1.
  • IL-1 and Corticosteroid.
  • In Vivo Action of IL-1.
  • Summary.
  • 2 Regulation of Human SAA Gene Expression by Cytokines.
  • In Vitro Expression of Human SAA.
  • Cis-acting Sequences Responsible for PMA Induction of SAA.
  • Cytokine Control of SAA Expression.
  • 3 Transcriptional Regulation of Acute Phase Response Genes with Emphasis on the Human C-reactive Protein Gene.
  • The Physiological Role of the Acute Phase Response.
  • Systems for the Study of the Acute Phase Response.
  • Monokines Responsible for the Modulation of Liver-specific Gene Expression.
  • Transcriptional Regulation — the Mechanism.
  • Liver-specific Promoters and Enhancers.
  • Promoters Induced During the Acute Phase.
  • Conclusions and Perspectives.
  • 4 Organization, Structure and Expression of Pentraxin Genes.
  • The Structure of Pentraxin Proteins.
  • The Structure of Pentraxin Genes.
  • Heat Shock Elements.
  • The Purine-Pyrimidine Repeat Region and Oligo-A Stretch in the CRP Intron.
  • The 3? Untranslated Region.
  • Elements Responding to Cytokines.
  • Genetics.
  • 5 ApoSSA: Structure, Tissue Expression and Possible Functions.
  • Background.
  • SAA is an Apolipoprotein.
  • Where are SAAs Made and Where do They go?.
  • Patterns of Cell and Tissue Expression of SAA mRNAs in Mice.
  • Rats Have SAA-related Genes.
  • 6 Regulation of Biosynthesis and Secretion of Human C-reactive Protein and Serum Amyloid A.
  • Regulation of Biosynthesis.
  • Role of Cytokines.
  • Role of Cofactors: Signal Transduction.
  • Heterogeneity in the Acute Phase Response.
  • Regulation of CRP Secretion.
  • Dynamics of CRP Secretion by Rabbit.
  • Hepatocytes.
  • Subcellular Localization of the Intracellular Pool of CRP.
  • CRP is Specifically Retained Within the Endoplasmic Reticulum.
  • Conclusions.
  • 7 Molecular Regulation of the Acute Phase Complement Proteins.
  • Factor B.
  • The Second Component, C2.
  • Constitutive Expression of Factor B and C2.
  • Regulated Gene Expression.
  • Interleukin-1 and Interferon-?.
  • Tumor Necrosis Factor and Interleukin-6.
  • 8 Biosynthesis of Acute Phase Proteins by the Liver Cells.
  • Role of Hepatocytes in the In Vivo Biosynthesis of APR.
  • Expression of APR in the Normal Unstimulated Liver.
  • Expression of APR During the AIR.
  • Role of Sinusoidal Cells in the In Vivo Biosynthesis of APR.
  • 9 The Plasma Serine Protease Inhibitors (Serpins): Structural Modifications in Inflammation.
  • The Serpins.
  • Structure of the Serpins.
  • Synthesis of Serpins in Inflammation.
  • Antitrypsin.
  • Antitrypsin Deficiency.
  • The Reactive Centre.
  • Mechanism of Protease Inhibition.
  • Specificity of Inhibition.
  • Reactive Centre Oxidation of Antitrypsin.
  • The SR Conformational Change.
  • Physiological Significance of the SR Change.
  • Pathological Significance of the SR Change.
  • Evolutionary Loss of the SR Change.
  • Other Structural Modifications in Inflammation.
  • N-terminal Cleavage: Angiotensinogen.
  • Modification of Carbohydrate.
  • 10 The Three Dimensional Structure of SAP.
  • 11 Structure, Metabolism and Function of Acute Phase High Density Lipoprotein.
  • Apo-SAA in Plasma.
  • Structure of Apo-SAA.
  • Structure of Acute Phase HDL.
  • Metabolic Function of Normal HDL.
  • Synthesis of Apo-SAA.
  • Plasma Clearance of Apo-SAA.
  • Cellular Association and Degradation of Apo-SAA.
  • Functions of Apo-SAA.
  • Concluding Remarks.
  • 12 Clinical Measurement of Acute Phase Proteins to Detect and Monitor Infectious Diseases.
  • Microbial Growth and AP Protein Response.
  • General Pattern of AP Protein Response in Infection.
  • Monitoring Disease Activity Using AP Protein Response.
  • AP Protein Response in Viral Infection.
  • Immunomodulation and AP Protein Response.
  • 13 C-reactive Protein: Clinical Aspects.
  • The Acute Phase Proteins.
  • The Erythrocyte Sedimentation Rate as an Indirect Indicator for the Acute Phase Reaction.
  • C-reactive Protein as a Direct Indicator of the Acute Phase Reaction.
  • Assays for CRP.
  • CRP Levels in Different Diseases.
  • Functions of CRP.
  • Conclusion.
  • 14 Pathogenesis of AA Amyloidosis.
  • Definition and Classification of Amyloidosis.
  • Serum and Tissue Amyloid A Proteins.
  • Structure of SAA and AA.
  • Induction and Production of the Acute Phase.
  • Protein SAA.
  • Apo SAA and “Apo AA”.
  • Displacement of SAA from HDL-SAA Complexes by Apo AI and Apo AII.
  • Formation and Deposition of AA Amyloid.
  • Incomplete Degradation of SAA.
  • Amyloid Enhancing Factor and Glycosaminoglycans.
  • Protein AP: The Amyloid “P Component”.
  • Summary of Some Current Hypotheses Regarding AA Amyloid Formation.
  • 15 Serum Amyloid P Component: A Specific Molecular Targeting Vehicle in Amyloidosis.
  • Serum Amyloid P Component.
  • Ligand Binding by SAP/AP.
  • Binding of SAP to Chromatin.
  • SAP and Amyloidosis.
  • Tissue Amyloid P Component.
  • SAP as a Targeting Vehicle in Amyloidosis.
  • Scintigraphic Imaging of Amyloid Deposits In Vivo.
  • Radiolabelled-SAP Studies in Experimental Murine Amyloidosis.
  • Mouse Imaging Studies Using 123I-Human SAP.
  • Mouse Imaging Studies Using 123I-Mouse SAP.
  • Localization of 125I-Pentraxins in AEF-Induced Amyloid.
  • 125I-SAP Localization as a Method of Quantitating Murine Amyloid Deposits.
  • Radiolabeled SAP Studies in Man.
  • Preparation of 123I-Human SAP for Clinical Studies.
  • Imaging of Human Amyloid Deposits.
  • Human SAP Turnover Studies.